[go: up one dir, main page]

WO2007085238A3 - Multifunctional mixture of active substances - Google Patents

Multifunctional mixture of active substances Download PDF

Info

Publication number
WO2007085238A3
WO2007085238A3 PCT/DE2007/000134 DE2007000134W WO2007085238A3 WO 2007085238 A3 WO2007085238 A3 WO 2007085238A3 DE 2007000134 W DE2007000134 W DE 2007000134W WO 2007085238 A3 WO2007085238 A3 WO 2007085238A3
Authority
WO
WIPO (PCT)
Prior art keywords
active substances
mixtures
multifunctional
relates
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2007/000134
Other languages
German (de)
French (fr)
Other versions
WO2007085238A2 (en
Inventor
Egon Tech
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE202006001133U external-priority patent/DE202006001133U1/en
Application filed by Individual filed Critical Individual
Priority to DE112007000709T priority Critical patent/DE112007000709A5/en
Publication of WO2007085238A2 publication Critical patent/WO2007085238A2/en
Publication of WO2007085238A3 publication Critical patent/WO2007085238A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to multifunctional mixtures of active substances that have preventive and therapeutic properties. Methods for producing said mixtures make use of the latest findings regarding quantum control while taking advantage of the behavior of biomolecules and minerals in an electromagnetic field. The invention also relates to the use of said mixtures of active substances as universal adjuvants for producing efficient vaccines against viral and cancer diseases. The invention further relates to the use of the disclosed multifunctional mixtures of active substances during the production of pharmaceutical compositions used for treating a wide spectrum of medical indications.
PCT/DE2007/000134 2006-01-24 2007-01-22 Multifunctional mixture of active substances Ceased WO2007085238A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE112007000709T DE112007000709A5 (en) 2006-01-24 2007-01-22 Multifunctional active ingredient mixture

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE202006001133.1 2006-01-24
DE202006001133U DE202006001133U1 (en) 2006-01-24 2006-01-24 Multifunctional active agent mixture, useful as auxiliary material in virus vaccine or vaccine to treat cancer, comprises fraction of specific peptide in polypetide chain and fraction with essential and non-essential amino acids
DE102006051941.8 2006-11-01
DE102006051941A DE102006051941A1 (en) 2006-01-24 2006-11-01 Multifunctional active agent mixture, useful as auxiliary material in virus vaccine or vaccine to treat cancer, comprises fraction of specific peptide in polypetide chain and fraction with essential and non-essential amino acids

Publications (2)

Publication Number Publication Date
WO2007085238A2 WO2007085238A2 (en) 2007-08-02
WO2007085238A3 true WO2007085238A3 (en) 2007-10-04

Family

ID=38219847

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2007/000134 Ceased WO2007085238A2 (en) 2006-01-24 2007-01-22 Multifunctional mixture of active substances

Country Status (2)

Country Link
DE (3) DE102006051941A1 (en)
WO (1) WO2007085238A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202007007542U1 (en) * 2007-05-26 2007-10-04 Tech, Egon Amino acid-mineral-peptide complex, in particular quantum mechanically modified, as a drug for the treatment of dementia

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4122585A1 (en) * 1991-07-08 1993-01-21 Horfervit Pharma Gmbh Use of peptide fraction obtd. from organs rich in reticuloendothelial cells - for promoting weight gain in treatment of cancer and microbial infection
WO1996030537A1 (en) * 1995-03-24 1996-10-03 Privates Institut Bioserv Gmbh Multi-factor immunity modulator mixture, process for its production and medicaments containing said modulators
WO2002066043A2 (en) * 2001-02-16 2002-08-29 Karl Hecht Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke
WO2005120487A2 (en) * 2004-06-11 2005-12-22 Egon Tech Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005027905A1 (en) 2004-06-11 2005-12-29 Egon Tech Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4122585A1 (en) * 1991-07-08 1993-01-21 Horfervit Pharma Gmbh Use of peptide fraction obtd. from organs rich in reticuloendothelial cells - for promoting weight gain in treatment of cancer and microbial infection
WO1996030537A1 (en) * 1995-03-24 1996-10-03 Privates Institut Bioserv Gmbh Multi-factor immunity modulator mixture, process for its production and medicaments containing said modulators
WO2002066043A2 (en) * 2001-02-16 2002-08-29 Karl Hecht Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke
WO2005120487A2 (en) * 2004-06-11 2005-12-22 Egon Tech Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders

Also Published As

Publication number Publication date
DE102006051941A1 (en) 2007-07-26
DE112007000709A5 (en) 2008-12-24
DE202007019590U1 (en) 2014-04-08
WO2007085238A2 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
WO2013009701A3 (en) Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
MY168791A (en) Carbamate compounds and of making and using same
MX2019001920A (en) Rna for cancer therapy.
WO2007054279A8 (en) Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
MX2010005631A (en) Novel cyclic hydrocarbon compounds for the treatment of diseases.
WO2011065800A3 (en) Pyrimidine derivative, method for preparing same and pharmaceutical composition containing same
WO2012075492A3 (en) Carbocycle-substituted purine and 7-deazapurine compounds
MX2007009960A (en) Combinations and modes of administration of therapeutic agents and combination therapy.
WO2008030818A3 (en) Novel liposome compositions
UA93599C2 (en) powder valgancyclovir preparation
MY159208A (en) A novel formulation of indomethacin
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
NZ598489A (en) Combination therapy for treating proliferative diseases
HK1217092A1 (en) Therapeutic compounds and uses thereof
WO2013071056A3 (en) Combination drug therapy for the treatment of solid tumors
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
WO2012142615A3 (en) Auranofin and auranofin analogs useful to treat proliferative disease and disorders
WO2006035204A3 (en) Combination comprising zd6474 and an imatinib
IL191797A0 (en) Combination of azd2171 and pemetrexed
TW200628473A (en) Novel heterocycles
IL164564A0 (en) Combination therapy for the treatment of cancer
WO2007071958A3 (en) Combination of zd6474 and pemetrexed
WO2007085238A3 (en) Multifunctional mixture of active substances
WO2010093615A3 (en) Compounds, their syntheses, compositions, and methods to treat cancer
WO2005092303A3 (en) Combination therapy with azd2171 and 5-fu and/or cpt-11

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
REF Corresponds to

Ref document number: 112007000709

Country of ref document: DE

Date of ref document: 20081224

Kind code of ref document: P

122 Ep: pct application non-entry in european phase

Ref document number: 07721860

Country of ref document: EP

Kind code of ref document: A2